EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens

Julia E Clark, Hannah Yejin Kim iD, Wendy W J van de Sande iD, Brendan McMullan iD, Paul Verweij iD, Ana Alastruey-Izquierdo iD, Arunaloke Chakrabarti iD, Thomas S Harrison iD, Felix Bongomin iD, Roderick J Hay iD, Rita Oladele iD, Jutta Heim und 10 weitere

Medical Mycology · 2024

DOI: 10.1093/mmy/myae044 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Mycology, 2024. Verfasst von Julia E Clark und 21 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Children's Hospital and School of Clinical Medicine, University of Queensland, St Lucia, Queensland, Australia. Hauptthemen laut MEDLINE: Mycetoma, Antifungal Agents, World Health Organization. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, WHO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization, in response to the growing burden of fungal disease, established a process to develop a fungal priority pathogens list. This systematic review aimed to evaluate the epidemiology and impact of eumycetoma. PubMed and Web of Science were searched to identify studies published between 1 January 2011 and 19 February 2021. Studies reporting on mortality, inpatient care, complications and sequelae, antifungal susceptibility, risk factors, preventability, annual incidence, global distribution, and emergence during the study time frames were selected. Overall, 14 studies were eligible for inclusion. Morbidity was frequent with moderate to severe impairment of quality of life in 60.3%, amputation in up to 38.5%, and recurrent or long-term disease in 31.8%–73.5% of patients. Potential risk factors included male gender (56.6%–79.6%), younger age (11–30 years; 64%), and farming occupation (62.1%–69.7%). Mycetoma was predominantly reported in Sudan, particularly in central Sudan (37%–76.6% of cases). An annual incidence of 0.1/100 000 persons and 0.32/100 000 persons/decade was reported in the Philippines and Uganda, respectively. In Uganda, a decline in incidence from 3.37 to 0.32/100 000 persons between two consecutive 10-year periods (2000–2009 and 2010–2019) was detected. A community-based, multi-pronged prevention programme was associated with a reduction in amputation rates from 62.8% to 11.9%. With the pre-specified criteria, no studies of antifungal drug susceptibility, mortality, and hospital lengths of stay were identified. Future research should include larger cohort studies, greater drug susceptibility testing, and global surveillance to develop evidence-based treatment guidelines and to determine more accurately the incidence and trends over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MycetomaAntifungal AgentsWorld Health OrganizationHumansIncidenceRisk FactorsMaleFemaleQuality of Life

Stichwörter der Autor:innen

Falciformispora senegalensisMadurella mycetomatisTrematosphaeria griseacomplicationseumycetomaincidencemycetomamycosisrisk factorsskinsubcutaneous tissue

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Queensland Children's Hospital and School of Clinical Medicine, University of Queensland, St Lucia, Queensland, Australia.
  • Infectious Diseases Institute (Sydney ID), The University of Sydney, Camperdown, New South Wales, Australia.
  • Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Camperdown, New South Wales, Australia.
  • Department of Pharmacy, Westmead Hospital, Westmead, New South Wales, Australia.
  • Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University of Rotterdam, Rotterdam, The Netherlands.
  • School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.

ORCID-Profile: Hannah Yejin Kim, Wendy W J van de Sande, Brendan McMullan, Paul Verweij, Ana Alastruey-Izquierdo, Arunaloke Chakrabarti, Thomas S Harrison, Felix Bongomin, Roderick J Hay, Rita Oladele, Peter Beyer, Valeria Gigante, Justin Beardsley, Hatim Sati, Jan-Willem Alffenaar, C Orla Morrissey

Förderung

  • World Health Organization
  • WHO

Zitieren

APA

Clark, J. E., Kim, H. Y., van de Sande, W. W. J., McMullan, B., Verweij, P., Alastruey-Izquierdo, A., Chakrabarti, A., Harrison, T. S., Bongomin, F., Hay, R. J., Oladele, R., Heim, J., Beyer, P., Galas, M., Siswanto, S., Dagne, D. A., Roitberg, F., Gigante, V., Beardsley, J., …, & Morrissey, C. O. (2024). Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens. Medical Mycology. https://doi.org/10.1093/mmy/myae044

Vancouver

Clark JE, Kim HY, van de Sande WWJ, McMullan B, Verweij P, Alastruey-Izquierdo A, et al. Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens. Medical Mycology. 2024. doi:10.1093/mmy/myae044

BibTeX
@article{Clark2024,
  author = {Clark, Julia E and Kim, Hannah Yejin and van de Sande, Wendy W J and McMullan, Brendan and Verweij, Paul and Alastruey-Izquierdo, Ana and Chakrabarti, Arunaloke and Harrison, Thomas S and Bongomin, Felix and Hay, Roderick J and Oladele, Rita and Heim, Jutta and Beyer, Peter and Galas, Marcelo and Siswanto, Siswanto and Dagne, Daniel Argaw and Roitberg, Felipe and Gigante, Valeria and Beardsley, Justin and Sati, Hatim and Alffenaar, Jan-Willem and Morrissey, C Orla},
  title = {Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens},
  journal = {Medical Mycology},
  year = {2024},
  doi = {10.1093/mmy/myae044}
}
Kostenlos starten →